References
- Zsóri G, Illés D, Terzin V, et al. Exocrine pancreatic insufficiency in type 1 and type 2 diabetes mellitus: do we need to treat it? A systematic review. Pancreatology. 2018;18(5):559–565.
- Søfteland E, Poulsen JL, Starup-Linde J, et al. Pancreatic exocrine insufficiency in diabetes mellitus - prevalence and characteristics. Eur J Intern Med [Internet]. 2019;68:18–22. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0953620519302547
- Terzin V, Várkonyi T, Szabolcs A, et al. Prevalence of exocrine pancreatic insufficiency in type 2 diabetes mellitus with poor glycemic control. Pancreatology. 2014;14(5):356–360.
- Demir K, Karaca C, Ahishali E, et al. A cross-sectional study to assess the prevalence of pancreatic exocrine insufficiency among diabetes mellitus patients in Turkey. Pancreas. 2016;45(7):e39–e40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27400162
- Vujasinovic M, Zaletel J, Tepes B, et al. Low prevalence of exocrine pancreatic insufficiency in patients with diabetes mellitus. Pancreatol. 2013;13(4):343–346.
- Campbell-Thompson M, Rodriguez-Calvo T, Battaglia M. Abnormalities of the exocrine pancreas in type 1 diabetes. Curr Diab Rep. 2015;15(10):75.
- Pandol SJ. Pancreatic secretion. In: Feldman M, Friedman L, Brandt L, editors. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease. 10th ed. Philadelphia (PA): Elsevier Saunders; 2016. p. 934–943.
- Owyang C, Logsdon CD. New insights into neurohormonal regulation of pancreatic secretion. Gastroenterology. 2004;127(3):957–969.
- Chey WY, Chang T-M. Secretin: historical perspective and current status. Pancreas. 2014;43(2):162–182.
- el Newihi H, Dooley CP, Saad C, et al. Impaired exocrine pancreatic function in diabetics with diarrhea and peripheral neuropathy. Dig Dis Sci. [Internet]. 1988;33(6):705–710. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2897272
- Chey WY, Chang T. Neural hormonal regulation of exocrine pancreatic secretion. Pancreatology. 2001;1(4):320–335.
- Chien H-J, Chiang T-C, Peng S-J, et al. Human pancreatic afferent and efferent nerves: mapping and 3-D illustration of exocrine, endocrine, and adipose innervation. Am J Physiol Gastrointest Liver Physiol. 2019;317(5):G694–706.
- Tesfaye S, Toronto Diabetic Neuropathy Expert Group, Boulton AJM, Dyck PJ, Freeman R, Horowitz M, Kempler P, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care [Care]. 2010;33(10):2285–2293. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2945176&tool=pmcentrez&rendertype=abstract
- Hardt PD, Ewald N. Exocrine pancreatic insufficiency in diabetes mellitus: a complication of diabetic neuropathy or a different type of diabetes? Exp Diabetes Res. 2011;2011:761950.
- Blake MR, Raker JM, Whelan K. Validity and reliability of the Bristol stool form scale in healthy adults and patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2016;44(7):693–703.
- Spallone V. Update on the impact, diagnosis and management of cardiovascular autonomic neuropathy in diabetes: what is defined, what is new, and what is unmet. Vol. 43Diabetes Diabetes Metab J. 2019;43(1):3–30.
- Vinik AI, Camacho PM, Davidson JA, Handelsman Y, Lando HM, Leddy AL, et al. American association of clinical endocrinologists and American college of endocrinology position statement on testing for autonomic and somatic nerve dysfunction. Endocr Pract. 2017;23(12):1472–1478.
- Sangnes DA, Søfteland E, Bekkelund M, et al. Wireless motility capsule compared with scintigraphy in the assessment of diabetic gastroparesis. Neurogastroenterol Motil [Internet]. 2019;32(4):e13771. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/nmo.13771.
- Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation [Internet]. 2007;115(3):387–397. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17242296
- Lugari R, Gnudi A, Dall'Argine P, et al. Diabetic autonomic neuropathy and impaired human pancreatic polypeptide secretion in response to food. J Clin Endocrinol Metab. 1987;64(2):279–282.
- Hossdorf T, Wagner M, Hoppe HW. Pancreatic polypeptide (PP) response to food in type I diabetics with and without diabetic autonomic neuropathy. Hepatogastroenterology. 1988;35(5):238–241.
- Glasbrenner B, Dominguez-Munoz E, Riepl RL, et al. Cholecystokinin and pancreatic polypeptide release in diabetic patients with and without autonomic neuropathy. Digest Dis Sci. 1995;40(2):406–411.
- Chowdhury RS, Forsmark CE. Review article: pancreatic function testing. Aliment Pharmacol Ther. 2003;17(6):733–750.
- Murphy JA, Criddle DN, Sherwood M, et al. Direct activation of cytosolic Ca2+ signaling and enzyme secretion by cholecystokinin in human pancreatic acinar cells. Gastroenterol. 2008;135(2):632–641.
- Liang T, Dolai S, Xie L, et al. Ex vivo human pancreatic slice preparations offer a valuable model for studying pancreatic exocrine biology. J Biol Chem. 2017;292(14):5957–5969.
- Erchinger F, Engjom T, Tjora E, et al. Quantification of pancreatic function using a clinically feasible short endoscopic secretin test. Pancreas [Internet]. 2013;42(7):1101–1106. Available from: https://insights.ovid.com/crossref?an=00006676-201310000-00008
- Lindkvist B, Nilsson C, Kvarnström M, et al. Importance of pancreatic exocrine dysfunction in patients with type 2 diabetes: a randomized crossover study. Pancreatology. 2018;18(5):550–558.
- Radlinger B, Ramoser G, Kaser S. Exocrine pancreatic insufficiency in type 1 and type 2 diabetes. Curr Diab Rep. 2020;20(6):18.
- Vinik AI, Casellini C, Parson HK, et al. Cardiac autonomic neuropathy in diabetes: a predictor of cardiometabolic events. Front Front Neurosci. 2018;12:591.
- Brock C, Søfteland E, Gunterberg V, et al. Diabetic autonomic neuropathy affects symptom generation and brain-gut axis. Diabetes Care [Internet]. 2013;36(11):3698–3705. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24026548
- Wegeberg AML, Brock C, Ejskjaer N, et al. Gastrointestinal symptoms and cardiac vagal tone in type 1 diabetes correlates with gut transit times and motility index. Neurogastroenterol Motil. 2020;33(1):e13885.
- Leeds JS, Oppong K, Sanders DS. The role of fecal elastase-1 in detecting exocrine pancreatic disease. Nat Rev Gastroenterol Hepatol. 2011;8(7):405–415.
- Vanga RR, Tansel A, Sidiq S, et al. Diagnostic performance of measurement of fecal elastase-1 in detection of exocrine pancreatic insufficiency: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2018;16(8):1220–1228.e4.
- Engjom T, Erchinger F, Laerum BN, et al. Diagnostic accuracy of a short endoscopic secretin test in patients with cystic fibrosis. Pancreas [Internet]. 2015;44(8):1266–1272. Available from: http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006676-201511000-00014
- Schönauer M, Thomas A, Morbach S, et al. Cardiac autonomic diabetic neuropathy. Diab Vasc Dis Res. 2008;5(4):336–344. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18958844
- Ewald N, Bretzel RG. Diabetes mellitus secondary to pancreatic diseases (Type 3c)-are we neglecting an important disease? Eur J Intern Med. 2013;24(3):203–206.